Corteva Agriscience logo

Corteva Agriscience

Last updated January 21, 2026
6
Innovation Areas
834
Inventors
7
Collaborations

Corteva Agriscience Research Landscape: Recent R&D and Innovation Focus Areas

This landscape reveals what Corteva Agriscience is actively researching on recently. It organizes signals from patents into clusters of real scientific and technical questions being explored, showing where Corteva Agriscience is repeatedly investing effort, building knowledge, and reducing uncertainty. The result is a forward-looking view of strategic intent , often visible months or years before it appears in products, partnerships, or financial disclosures of Corteva Agriscience.

What are Corteva Agriscience's key R&D focus areas?

Pyridine carboxylate herbicidal compositions

(2)problems

Engineering specific pyridine carboxylate molecular structures to selectively inhibit plant growth. This creates value through high-potency weed control with crop-specific safener compatibility.

Site specific transgene integration

(2)problems

The precise targeting of transgenes into specific genomic sites and promoters is being engineered. This controls gene expression predictability and avoids random insertional mutagenesis in plant breeding.

1,2,4-triazolyl 4-oxothiazole heterocyclic scaffold

(3)problems

Engineering of novel chemical structures to selectively disrupt physiological pathways in invertebrate pests. This creates value through high-potency targeted toxicity across multiple agricultural vectors.

Imidazopyridine carboxylic acid synthesis

(4)problems

The concentration and strength of basic species are controlled to drive chemical reactions. This enables selective deprotonation and nucleophilic activation in synthetic pathways.

Aryl amidine and picolinamide scaffolds

(2)problems

Molecular structures engineered to inhibit fungal metabolic pathways. This provides targeted crop protection and prevents pathogenic proliferation.

Copi coatomer subunit rnai silencing

(1)problems

The engineering of amino acid sequences and cellular expression vectors to synthesize functional proteins. This enables the production of targeted therapeutics and industrial biocatalysts.